HIKAL
Quarterly Results Analysis [Mar2026]
HIKAL Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹519 Cr | ₹494 Cr | ₹319 Cr | ₹380 Cr | ₹552 Cr | ₹448 Cr | ₹453 Cr | ₹407 Cr |
| Expenses | ₹414 Cr | ₹412 Cr | ₹311 Cr | ₹355 Cr | ₹429 Cr | ₹376 Cr | ₹378 Cr | ₹349 Cr |
| Operating Income | ₹105 Cr | ₹83 Cr | ₹7 Cr | ₹25 Cr | ₹123 Cr | ₹72 Cr | ₹75 Cr | ₹58 Cr |
| Other Income | ₹7 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹4 Cr | ₹0 Cr | ₹1 Cr |
| Interest | ₹15 Cr | ₹16 Cr | ₹15 Cr | ₹17 Cr | ₹18 Cr | ₹19 Cr | ₹19 Cr | ₹20 Cr |
| Depreciation | ₹42 Cr | ₹41 Cr | ₹41 Cr | ₹39 Cr | ₹38 Cr | ₹33 Cr | ₹32 Cr | ₹32 Cr |
| Profit Before Tax | ₹8 Cr | ₹-9 Cr | ₹-47 Cr | ₹-30 Cr | ₹68 Cr | ₹24 Cr | ₹25 Cr | ₹7 Cr |
| Profit After Tax | ₹14 Cr | ₹-6 Cr | ₹-35 Cr | ₹-22 Cr | ₹50 Cr | ₹17 Cr | ₹18 Cr | ₹5 Cr |
| EPS | ₹1.17 | ₹-0.48 | ₹-2.83 | ₹-1.81 | ₹4.06 | ₹1.39 | ₹1.48 | ₹0.41 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HIKAL | 15% | 6.6% | -45.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 3.5% | -1.5% | 9% |
| DIVIS LABORATORIES | 1.1% | -1.1% | 0.8% |
| TORRENT PHARMACEUTICALS | -0.2% | -0.3% | 35% |
| CIPLA | 3.1% | 1% | -11.3% |
| DR REDDYS LABORATORIES | 1.1% | -2.1% | -5.6% |
| MANKIND PHARMA | 7.7% | 0.9% | 2.1% |
| LUPIN | 2.7% | 2.4% | 17% |
| ZYDUS LIFESCIENCES | 0.6% | 4.7% | 10% |
HIKAL Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 5.08 % |
| Y-o-Y | -5.97 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹519 Cr | 5.08 | |
| Dec2025 | ₹494 Cr | 55.20 | |
| Sep2025 | ₹319 Cr | -16.27 | |
| Jun2025 | ₹380 Cr | -31.14 | |
| Mar2025 | ₹552 Cr | 23.39 | |
| Dec2024 | ₹448 Cr | -1.15 | |
| Sep2024 | ₹453 Cr | 11.33 | |
| Jun2024 | ₹407 Cr | - | |
HIKAL Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 27.45 % |
| Y-o-Y | -14.59 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹105 Cr | 27.45 | |
| Dec2025 | ₹83 Cr | 1,048.61 | |
| Sep2025 | ₹7 Cr | -71.31 | |
| Jun2025 | ₹25 Cr | -79.66 | |
| Mar2025 | ₹123 Cr | 71.15 | |
| Dec2024 | ₹72 Cr | -3.74 | |
| Sep2024 | ₹75 Cr | 29.14 | |
| Jun2024 | ₹58 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 21.28 % |
| Y-o-Y | -9.18 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 20.29% | 21.28 | |
| Dec2025 | 16.73% | 640.27 | |
| Sep2025 | 2.26% | -65.76 | |
| Jun2025 | 6.6% | -70.46 | |
| Mar2025 | 22.34% | 38.76 | |
| Dec2024 | 16.1% | -2.66 | |
| Sep2024 | 16.54% | 15.99 | |
| Jun2024 | 14.26% | - | |
HIKAL Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | -71.31 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 Cr | Positive | |
| Dec2025 | ₹-6 Cr | Negative | |
| Sep2025 | ₹-35 Cr | Negative | |
| Jun2025 | ₹-22 Cr | Negative | |
| Mar2025 | ₹50 Cr | 191.86 | |
| Dec2024 | ₹17 Cr | -6.01 | |
| Sep2024 | ₹18 Cr | 258.82 | |
| Jun2024 | ₹5 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | -69.53 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 2.77 % | Positive | |
| Dec2025 | -1.19 % | Negative | |
| Sep2025 | -10.96 % | Negative | |
| Jun2025 | -5.89 % | Negative | |
| Mar2025 | 9.09 % | 136.72 | |
| Dec2024 | 3.84 % | -4.95 | |
| Sep2024 | 4.04 % | 223.20 | |
| Jun2024 | 1.25 % | - | |
HIKAL Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | Positive |
| Y-o-Y | -71.18 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.17 | Positive | |
| Dec2025 | ₹-0.48 | Negative | |
| Sep2025 | ₹-2.83 | Negative | |
| Jun2025 | ₹-1.81 | Negative | |
| Mar2025 | ₹4.06 | 192.09 | |
| Dec2024 | ₹1.39 | -6.08 | |
| Sep2024 | ₹1.48 | 260.98 | |
| Jun2024 | ₹0.41 | - | |
You may also like the below Video Courses